Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116178153A discloses novel monodentate phosphine ligands enabling high-yield, high-ee palladium-catalyzed Tsuji-Trost reactions for cost-effective pharmaceutical intermediate manufacturing.
Novel chiral ligand enables high ee copper catalysis. Reduces cost in pharmaceutical intermediates manufacturing. Reliable supply chain partner.
Discover the advanced PBr3-Grignard route for air-stable trialkyl phosphine borofluoride. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN102464681A discloses a stable chiral bidentate phosphite ligand for asymmetric synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN100473640C details a novel resolution method for trans-2,3-diamino-1,2,3,4-tetrahydronaphthalene using tartaric acid derivatives, offering high ee values and scalable manufacturing.
Patent CN113024615A discloses efficient chiral ligands enabling cheap metal catalysis for API synthesis, offering significant cost reduction and supply chain stability.
Patent CN115772195A reveals novel pyridine-based diphosphine ligands achieving >99% selectivity and TON >50000 in olefin alkoxycarbonylation for cost-effective ester production.
Patent CN103189383B details novel biaryl diphosphine ligands enabling cost reduction in pharmaceutical intermediates manufacturing through improved asymmetric catalysis and scalability.
Explore the novel synthesis of chiral oxazoline-zinc complexes via patent CN102212078A, offering robust catalytic solutions and supply chain stability for pharmaceutical manufacturing.
Novel BF3 catalyzed route offers high yield and stability. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Patent CN104109174B introduces a novel ligand for asymmetric methoxycarbonylation, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Patent CN113004326B discloses advanced bidentate phosphine ligands enhancing adipaldehyde selectivity up to 60%, offering a viable route for nylon precursors.
Novel patent CN110878104B details a safer two-step route for chiral 1,2-bis(2,5-diphenylphosphino)ethane, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN109776422B discloses novel chiral carbene precursors enabling high-selectivity hydroboration. Discover cost-effective synthesis and supply chain advantages.
Discover novel pyrroline chiral bisphosphine ligands from patent CN110041365B. High enantioselectivity synthesis for reliable pharmaceutical intermediate supply chains.
Novel patent CN117924283A details high-yield spiro compound synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN108659043B details a cost-effective CAN-catalyzed route for E-alkenyl diphenylphosphines, offering superior atom economy and simplified purification for pharmaceutical intermediates.
Novel pyridine-amide-oxazoline ligands enable high-yield asymmetric hydroboration. Efficient synthesis reduces costs for pharmaceutical intermediate manufacturing supply chains.
Advanced NCP ligand iridium complexes enable efficient alkane dehydrogenation and α-alkylation with high selectivity and stability for industrial scale-up.